Correction: The KRAS-G12C inhibitor: activity and resistance (Cancer Gene Therapy, (2022), 29, 7, (875-878), 10.1038/s41417-021-00383-9)

Correction to: Cancer Gene Therapy (2021) 29:875–878 , published online 01 September 2021 in the 3rd paragraph, 6th sentence of the Introduction, “Compared with the wild-type, the KRAS mutation disrupts the guanine exchange cycle, thereby locking it in an inactive GDP-bound form that drives pro-tumorigenic signals [18] (Fig. 1b).” Should be changed to: “Compared with the wild-type, the KRAS mutation disrupts the guanine exchange cycle, thereby locking it in an active GTP-bound form that drives pro-tumorigenic signals [18] (Fig. 1b).” The original article has been corrected.